Risk Factors Associated with Surgical Site Infection following Cesarean Section in Tertiary Care Hospital, Nepal.
Journal
International journal of reproductive medicine
ISSN: 2356-7104
Titre abrégé: Int J Reprod Med
Pays: Egypt
ID NLM: 101633172
Informations de publication
Date de publication:
2022
2022
Historique:
received:
31
08
2021
accepted:
08
04
2022
entrez:
26
5
2022
pubmed:
27
5
2022
medline:
27
5
2022
Statut:
epublish
Résumé
Cesarean section (CS) is one of the most performed surgeries in obstetrics. Surgical site infection is the major cause of morbidity and mortality causing an increase in the duration of hospitalization as well as the cost of admission for the patient. To determine incidence of surgical site infection following cesarean section, classify them according to CDC criteria, and identify the different risk factors. Out of 1135 cases of cesarean sections, 97 of them developed SSI with incidence rate of 8.54%. Among them, 94.85% were superficial incisional and 5.15% were deep incisional type of SSI with no organ space type. Cases had higher mean age 26.88 ± 4.38 years compared to 24.81 ± 5.08 years in controls. Host-related risk factors which led to higher odds of developing surgical site infection (SSI) were obesity with adjusted odds ratio (AOR) 15.72 (confidence interval (CI): 4.60-53.67), diabetes/hypertension in pregnancy with AOR 4.75(CI 1.69-13.32), and other medical diseases with AOR 9.38 (CI 2.89-30.46). Duration of the rupture of membrane for more than 18 hours with AOR 8.38 (CI 1.48-47.35), more than five per vaginal (PV) examination with AOR 1.93 (95% CI 1.03-3.64), and in labor status with AOR 6.52 (CI 1.17-36.38) were some procedure-related factors resulting into higher odds of infection. Multiple risk factors like age, obesity, medical complications during pregnancy, occurrence of labor status during cesarean section, prolonged duration of rupture of membrane for more than 18 hours, and more than five vaginal examinations before the procedure increases the chance of surgical site infection (SSI) following cesarean section.
Sections du résumé
Background
UNASSIGNED
Cesarean section (CS) is one of the most performed surgeries in obstetrics. Surgical site infection is the major cause of morbidity and mortality causing an increase in the duration of hospitalization as well as the cost of admission for the patient.
Objective
UNASSIGNED
To determine incidence of surgical site infection following cesarean section, classify them according to CDC criteria, and identify the different risk factors.
Results
UNASSIGNED
Out of 1135 cases of cesarean sections, 97 of them developed SSI with incidence rate of 8.54%. Among them, 94.85% were superficial incisional and 5.15% were deep incisional type of SSI with no organ space type. Cases had higher mean age 26.88 ± 4.38 years compared to 24.81 ± 5.08 years in controls. Host-related risk factors which led to higher odds of developing surgical site infection (SSI) were obesity with adjusted odds ratio (AOR) 15.72 (confidence interval (CI): 4.60-53.67), diabetes/hypertension in pregnancy with AOR 4.75(CI 1.69-13.32), and other medical diseases with AOR 9.38 (CI 2.89-30.46). Duration of the rupture of membrane for more than 18 hours with AOR 8.38 (CI 1.48-47.35), more than five per vaginal (PV) examination with AOR 1.93 (95% CI 1.03-3.64), and in labor status with AOR 6.52 (CI 1.17-36.38) were some procedure-related factors resulting into higher odds of infection.
Conclusion
UNASSIGNED
Multiple risk factors like age, obesity, medical complications during pregnancy, occurrence of labor status during cesarean section, prolonged duration of rupture of membrane for more than 18 hours, and more than five vaginal examinations before the procedure increases the chance of surgical site infection (SSI) following cesarean section.
Identifiants
pubmed: 35615602
doi: 10.1155/2022/4442453
pmc: PMC9126726
doi:
Types de publication
Journal Article
Langues
eng
Pagination
4442453Informations de copyright
Copyright © 2022 Astha Regmi et al.
Déclaration de conflit d'intérêts
The authors declare that they have no conflicts of interest.
Références
Obstet Gynecol. 2007 Mar;109(3):669-77
pubmed: 17329519
J Hosp Infect. 2014 Jan;86(1):24-33
pubmed: 24268456
Antimicrob Resist Infect Control. 2014 Aug 11;3:25
pubmed: 25126415
Ann Med Health Sci Res. 2012 Jan;2(1):33-6
pubmed: 23209988
J Obstet Gynaecol Res. 2012 Mar;38(3):509-15
pubmed: 22353388
Acta Obstet Gynecol Scand. 2007;86(9):1097-102
pubmed: 17712651
Braz J Infect Dis. 2015 Mar-Apr;19(2):113-7
pubmed: 25529364
Infect Control Hosp Epidemiol. 2001 Oct;22(10):613-7
pubmed: 11776346
BJOG. 2012 Oct;119(11):1324-33
pubmed: 22857605
Clin Infect Dis. 2005 Nov 15;41(10):1373-406
pubmed: 16231249
East Mediterr Health J. 2003 Sep-Nov;9(5-6):1068-74
pubmed: 16450539
Am J Infect Control. 1992 Oct;20(5):271-4
pubmed: 1332552
Int J Gynaecol Obstet. 2005 Jul;90(1):10-5
pubmed: 15913620
Am J Perinatol. 2016 Jan;33(2):157-64
pubmed: 26344010
Obstet Gynecol. 2000 Jun;95(6 Pt 1):923-6
pubmed: 10831993
Am J Infect Control. 2005 May;33(4):217-26
pubmed: 15877016
Kathmandu Univ Med J (KUMJ). 2014 Apr-Jun;12(46):113-6
pubmed: 25552215
J Hosp Infect. 2006 Oct;64(2):156-61
pubmed: 16899325
Am J Infect Control. 2019 Feb;47(2):164-169
pubmed: 30253904
Obstet Gynecol. 2013 Apr;121(4):789-797
pubmed: 23635679
Int J Womens Health. 2017 Feb 17;9:81-88
pubmed: 28255256